Litcius/Paper detail

Prevalence, risk factors and molecular epidemiology of carbapenem-resistant <i>Klebsiella pneumoniae</i> in patients from Zhejiang, China, 2008–2018

Yanyan Hu, Congcong Liu, Zhangqi Shen, Hongwei Zhou, Junmin Cao, Shi Chen, Huoyang Lv, Mingming Zhou, Qiang Wang, Long Sun, Qiaoling Sun, Fupin Hu, Yang Wang, Rong Zhang

2020Emerging Microbes & Infections177 citationsDOIOpen Access PDF

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is emerging as a worldwide public health concern; however, the long-term molecular epidemiological surveillance of clinical CRKP in China is limited. We conducted a retrospective observational study (2008–2018) to assess the prevalence, susceptibility, risk factors and molecular epidemiology of clinical CRKP isolates. We found the prevalence of CRKP increased from 2.5%, 2008 to 15.8%, 2018. CRKP were significantly more frequent among hospitalized patients from ICU, and it was significantly more likely to be isolated from the capital city (Hangzhou) and the patients aged ≥60 years. Additionally, seasons and specimen types were associated with CRKP infections. The main CRKP sequence type (ST) was ST11, and blaKPC-2 was the most prevalent gene variant. Together these data reveal an increasing incidence and resistance trends among CRKP, especially the ST11-blaKPC-2-CRKP, in Zhejiang, during 2008–2018. Our findings are important for hospitals to limit its dissemination and optimize antibiotic administration.

Topics & Concepts

EpidemiologyKlebsiella pneumoniaeMolecular epidemiologyIncidence (geometry)Antibiotic resistanceMedicineObservational studyInternal medicineAntibioticsEnvironmental healthMicrobiologyBiologyGenotypeGeneGeneticsEscherichia coliOpticsPhysicsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance
Prevalence, risk factors and molecular epidemiology of carbapenem-resistant <i>Klebsiella pneumoniae</i> in patients from Zhejiang, China, 2008–2018 | Litcius